Key Dates

Related Announcements

• August 26, 2024 - Research Resource for Human Organs and Tissues (U42 Clinical Trial Not Allowed). See NOFO PAR-24-258.

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that effective immediately the National Heart, Lung, and Blood Institute (NHLBI) will participate in PAR-24-258, "Research Resource for Human Organs and Tissues (U42 Clinical Trial Not Allowed)". 

The following text in bold and italics has been added to reflect NHLBI's participation:

Part 1. Overview Information

Components of Participating Organizations

Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)

National Eye Institute (NEI)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute on Deafness and Other Communication Disorders (NIDCD), July 3, 2025 - Participation added (NOT-DC-25-030)

National Heart, Lung, and Blood Institute (NHLBI)

Assistance Listing Number(s)

93.351, 93.855, 93.867, 93.847, 93.846, 93.173, 93.837, 93.838, 93.839, 93.840, 93.233

Section VII. Agency Contacts

Division of Lung Diseases
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Subject: PAR-24-258

Office of Grants Management
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Subject: PAR-24-258

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries regarding this Notice to:

Scientific/Research Contact(s)

Division of Lung Diseases
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Subject: PAR-24-258

Financial/Grants Management Contact(s)

Office of Grants Management
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Subject: PAR-24-258